CytomX Therapeutics CTMX Market capitalization
Market capitalization at other companies
Other financials
Where this comes from
Computed from the period-end share price: $1.02B.
The official record: CytomX Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about CytomX Therapeutics's market capitalization.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is CytomX Therapeutics's market capitalization?
- CytomX Therapeutics (CTMX) reported market capitalization of $1.02B in Q1 2026.
- How has CytomX Therapeutics's market capitalization changed year-over-year?
- CytomX Therapeutics's market capitalization increased by 1895.1% year-over-year, from $50.93M to $1.02B.
- What is the long-term trend for CytomX Therapeutics's market capitalization?
- Over 5 years (2020 to 2025), CytomX Therapeutics's market capitalization has grown at a 11.1% compound annual growth rate (CAGR), from $427.38M to $721.79M.
- What does market capitalization mean?
- The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.